chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within an hour of getting the vaccines, the left side of my neck began to tighten up( 3/10). Three hours later it had increased in severity to 6/10 and I took 2 Tylenols as instructed by my pharmacist. These did not help. 4 hours later, still at 6-7/10, I took an Ibuprofen 800mg with relief going down to 3-4/10. The following morning ( this am), initially the pain was 1/10, more of an inconvenient tightenting. After an hour the pain had increased to 4/10, mostly with an up and down motion of the head. Side to side motion maybe a 1/10. 3 hours later,  discomfort reduced to 2/10, not noticible while working. There is no tenderness at the injection sites.
Headache, Myalgia, Arthralgia & NauseaVomiting Narrative: Employee reports began experiencing symptoms the morning after receiving vaccine. Reports symptoms of injection site pain, chills, headaches which felt like migraines, joint pain, body aches, fatigue, and nausea. Employee does note history of COVID-19 infection in December 2020. Reported taking Tylenol 650mg x 2 doses for symptom relief. No other medications reported. Employee has since recovered.
Dizziness; Doesnt want to go away difficult tofunction; Bad head ache; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8735) via an unspecified route of administration in the left arm on 30Apr2021 at 00:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies.The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8733) via an unspecified route of administration in the left arm on 09Apr2021 at 00:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 13:15, the patient experienced bad head ache, dizziness, nausea, fatigue x2 weeks, doesn't want to go away difficult to function. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events bad headache, dizziness, nausea, fatigue, doesn't want to go away difficult to function was not recovered.  No follow-up attempts are needed. No further information is expected.
Day 2-4:  Slight achiness in left arm surrounding injection site, typical of other vaccinations I've received in the past. Day 10:  Slight dizziness and moderate nausea, including multiple episodes of vomiting.  This lasted 6-8 hours before resolving without medical attention.  Dizziness and nausea are not typical for me.
Patient reports sore arm one month after vaccine administaration. She believes it is due to technique.
Felt like she was going to die; Had an extremely horrific reaction to moderna; So incredibly sick; This spontaneous case was reported by a consumer and describes the occurrence of FEAR OF DEATH (Felt like she was going to die), IMMUNISATION REACTION (Had an extremely horrific reaction to moderna) and ILLNESS (So incredibly sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jul-2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEAR OF DEATH (Felt like she was going to die), IMMUNISATION REACTION (Had an extremely horrific reaction to moderna) and ILLNESS (So incredibly sick). At the time of the report, FEAR OF DEATH (Felt like she was going to die), IMMUNISATION REACTION (Had an extremely horrific reaction to moderna) and ILLNESS (So incredibly sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   Patient had an extremely horrific reaction to Moderna. She received product, it was great. States she had an adverse event felt like she was going to die. Horrific experience. Had antibodies from Moderna, no T cells.  No treatment medication was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
for 2 weeks had congestion and 99.1 temperature; really bad diarrhea and vomiting; really bad diarrhea and vomiting; . She has now been exposed to someone that had Covid; for 2 weeks had congestion and 99.1 temperature; This is a spontaneous report from a non-contactable consumer or other non hcp.  A 80-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection via an unspecified route of administration on 20Mar2021 (Batch/Lot number was not reported, expiry date: unknown) as dose 1, single (age at vaccination:80-Years-old) for COVID-19 immunisation. The patient medical history was not reported and none concomitant medications were reported. It was reported that patient received the Pfizer vaccine back on 20Mar and she talked to somebody that had a horrible accent and was hard to understand. They didn't answer her question, just asked a lot of questions. On that day of her vaccine, she ended up getting really bad diarrhea and vomiting. She is 80 years old and is concerned about the second dose. She has now been exposed to someone that had Covid and she has for 2 weeks had congestion and 99.1 temperature. Should she get the second dose that is schedule for this Saturday which was scheduled at 4 weeks. On an unspecific date the patient underwent lab tests and procedures which included body temperature: 99.1. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
11 hrs. after receiving  vaccine at 9:00 a.m. experiencing chills, 102 fever, dizziness, headache, body aches at 8:00 that evening
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 19-FEB-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L040178, expiration date 18-AUG-2017). This specified lot number vaccine was exposed to temperature excursion two times. The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of 34 Fahrenheit degree. The total cumulative excursion time of the second time was 16 hours with the lowest recorded temperature of 29 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
In approximately August 1999, pt was vaccinated with Hep-A and he  experienced an elevated ALT level - 93U/L.  A baseline ALT had previously been normal. Additional information has been requested.
Skin was super-sensitive for a month, especially on the back of my head. I also randomly breakout.
Some diarrhea; Extreme pain at site injection point.; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on 07Apr2021 at 16:00 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included cholesterol levels had stabilized and arthritis in right hip. The patient had no known allergies to medications, food, or other products. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN) and lovastatin (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 04Mar2021 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 16:00, the patient experienced extreme pain at site injection point that lingered until 08Apr2021 and on 09Apr2021, in morning, the patient's arm felt fine. On 09Apr2021, the patient experienced some diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events extreme pain at site injection point and some diarrhea was resolved on 09Apr2021.   No follow-up attempts are needed. No further information is expected.
Chills 24 hours Body aches 24 hours, started 2 hours after vaccine Exhaustion/fatigue 60 hours, started 2 hours after vaccine Confusion/brain fog, feeling spaced out stated 2 hours after vaccine lasted 4 days  Fever started at 9 pm, latex about 12 hours. Ten 101.5°
This spontaneous case reported by a consumer, describes the occurrence of fatigue (after first dose) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 026L20A) for COVID-19 immunization. No medical history reported. Concomitant products included Effexor (venlafaxine hydrochloride) for depression; propranolol and hydroxyzine for anxiety. On Dec 30, 2020, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient had fatigue (after first dose). At the time of the report, fatigue (after first dose) outcome: unknown. The reporter did not provide any causality assessments or treatment information. Concomitant products included unknown drug for birth control. This case linked to MOD-2021-377816, MOD-2021-378042 (patient link).
Narrative: Patient received two doses of Pfizer COVID 19 Vaccine in Mar/Apr 2021. The patient presented to the ED on 4 June 2022 with confusion and cough. The patient tested positive for COVID 19 and was admitted with COVID 19 encephalopathy. The patient was treated with supportive care. The patient was discharged in stable condition on 6 June 2022.
On 07/19/2001 the patient developed a rash on the right thigh with pain and itching. On 07/20/2001 the patient was seen by a physician for moderate erythema, warmth and edema to the dorsal right thigh. The patient was treated with Claritin and cool compresses to the area.
redness; bumpy under the injection site; Rash on upper arm around the injection site (6 inches long).; Itchy around the injection site; Warm to the touch around the injection site; soreness in left arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in left arm), FATIGUE (Fatigue), INJECTION SITE RASH (Rash on upper arm around the injection site (6 inches long).), INJECTION SITE PRURITUS (Itchy around the injection site) and INJECTION SITE WARMTH (Warm to the touch around the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included Prilosec OTC for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness in left arm) and FATIGUE (Fatigue). On 27-Feb-2021, the patient experienced INJECTION SITE RASH (Rash on upper arm around the injection site (6 inches long).), INJECTION SITE PRURITUS (Itchy around the injection site) and INJECTION SITE WARMTH (Warm to the touch around the injection site). On 09-Mar-2021, the patient experienced INJECTION SITE SWELLING (bumpy under the injection site). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness). At the time of the report, PAIN IN EXTREMITY (soreness in left arm), FATIGUE (Fatigue), INJECTION SITE RASH (Rash on upper arm around the injection site (6 inches long).), INJECTION SITE PRURITUS (Itchy around the injection site), INJECTION SITE WARMTH (Warm to the touch around the injection site), INJECTION SITE SWELLING (bumpy under the injection site) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Eucerin cream..    Reporter did not allow further contact
Information has been received from a 27 year old female consumer with a history of yeast infection (after taking antibiotics) and allergic reaction to antibiotics telithromycin KETEK and levofloxacin LEVAQUIN, who on 12-MAR-2007 was vaccinated with a third dose of Gardasil. There was no concomitant medication. On 26-MAR-2007, the consumer developed a yeast infection two weeks later. It was reported that the consumer was initially treated with antibiotics (name not known) for treatment of what they thought was a urinary tract infection. She was then given fluconazole (DIFLUCAN) which did not resolve the yeast infection, and metronidazole (FLAGYL) which still has not resolved the yeast infection. It was reported that the consumer continues to experienced burning, itching and discomfort. Her symptoms have not changed in intensity. On 07-JUN-2007, a culture was taken that showed a yeast infection. It was reported that the consumer did not experience any difficulties after the last two vaccinations. At the time of this report, the consumer was reported to be recovering. It was reported that on 26-AUG-2006, the patient was vaccinated IM with a 0.5ml dose of Gardasil (Lot # 654540/0800F). No product quality complaint was involved. Additional information has been requested. This is in follow-up to report(s) previously submitted on 7-16/2007. Information has been received from a 27 year old female consumer with a history of yeast infection (after taking antibiotics), endometriosis and allergic reaction to antibiotics KETEK and LEVAQUIN, who on 12-MAR-2007 was vaccinated into the left hip with a third dose of GARDASIL (Lot # 654540/0800F). There was no concomitant medication. About one week after the vaccination, the patient experienced severe itching, burning and pain. On 26-MAR-2007 two weeks later, the consumer developed a yeast infection. It was reported that the consumer was initially treated with antibiotics SEPTRA DS, MACRODANTIN for treatment of what they thought was a urinary tract infection. She was then given DIFLUCAN which did not resolve the yeast infection, and FLAGYL which still has not resolved the yeast infection. On 07-JUN-2007, a culture was taken that showed a yeast infection. It was reported that the consumer did not experience any difficulties after the last two vaccinations. It was reported that the symptoms lasted for two and a half months. Subsequently, the patient was recovering from yeast infection. It was reported that on 26-AUG-2006, the patient was vaccinated IM with a 0.5ml dose of GARDASIL (Lot # 654540/0800F). No product quality complaint was involved. Additional information is not expected.
Left distal wrist soreness started 10/3/13 am then 10/4/13 am right distal wrist soreness. Over the counter ASA taken. Pinkness slightly and a bit itchy at injection site mild.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 51 year old female. Initial information was processed with the additional information received on 09-JUN-2022. The patient's height, and weight were not reported. The patient's concurrent conditions included: very low level hashimotos (not taking medication), drug allergy and other pre-existing medical conditions included: The patient was not taking any other medications/products within 2 weeks of starting COVID-19 (corona virus disease) treatment. The patient was not pregnant at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown, expiry: unknown) dose was not reported, 1 total, administered on 04-APR-2021 to right arm for prophylactic vaccination. The batch number was not reported and has been requested. Age at time of vaccination 50 years old.  The patient received non company suspect Paxlovid (form of administration and route of administration were not reported, batch number: unknown, expiry: unknown) dose was not reported, administered from 03-MAY-2022 to 08-MAY-2022 for treatment of COVID-19. No concomitant medications were reported.  On 13-MAY-2022 at 14:00 (Friday night), the patient had night onset of fever, runny nose, sneezing, exhaustion (after contacting virus) and experienced the events of suspected covid-19 infection and suspected clinical vaccination failure. The fever lasted for one night and all other symptoms lasted for a week.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable and action taken with Paxlovid was not reported. The patient recovered from suspected covid-19 infection on 26-MAY-2022, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000234825; Sender's Comments: V0: 20220607940-covid-19 vaccine ad26.cov2.s-suspected clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Nausea, Dizziness, anxiousness, elevated Blood pressure, dry mouth, tachycardia
No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 49-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 13-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.).      No concomitant medications were reported. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was reported that 113 Bivalent doses administered after the BUD to patients 12 and up. Breakdown of doses was 51 doses from lot AS7140C and 60 doses from lot AS7148B. No treatment details were reported.
increased resting heart rate from normal 60-80bpm to >100bpm, heaviness in chest physical exam, blood work, CT scan, EKG, ECHO & cardiologist consult no other signs/sxs of cardiac issues, considered immune response from vaccine
RIGHT UPPER ARM RED AND SWOLLEN. AREA MEASURED  12.5 CM BY 13.5 CM. WARM, ERYTHEMA, MILD TENDERNESS. NO BRUISING.
slight pain in his arm the shot was given; if he moved his arm, he would have slight discomfort; some slight tenderness in his shoulder; Yesterday, his temperature was 97 something. This morning, he got up at 6am and his temperature was around 98.8; This is a spontaneous report from a contactable consumer (patient). An 83-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9261; expiry date: unknown) via an unspecified route of administration in the left arm, on 26Jan2021 at 8:30 to 9 AM, at a single dose, for Covid-19 immunization. Medical history in Mar2020 included had a temperature for 7 days. He tested positive for COVID and it took a while to test negative. At the end of Mar2020 until the first of Apr2020, his temperature was 97 something. He has checked his temperature every day since then. There were no concomitant medications. The patient had no previous immunization with the Pfizer vaccine. He did not receive additional vaccines on the same date bnt162b2 was given. The patient had his first COVID-19 shot yesterday morning about 8:30 or 9:00. He hadn't really looked at the list of side effects, but yesterday afternoon (26Jan2021), he had slight pain in the arm where the shot was given. If he moved his arm, he would have slight discomfort. The pain was mostly gone today. He also had some slight tenderness in his shoulder, but it's certainly less than what it was yesterday. He saw other things that were listed including fever. He wanted to know if Pfizer had any information as what to amount of fever people typically experience after having the shot.  Yesterday (unspecified date in Jan2021), his temperature was 97 something. This morning, he got up at 6 am and his temperature was around 98.8. And then he had to take his wife to therapy and when he got back 3 hours later, he took it now and his temperature was 99 degrees. He was just wondering if Pfizer had an idea of how much fever is normal from the shot?  He hasn't had any other reactions. The events did not require Emergency Room or Physician's Office visit. The patient underwent lab tests and procedures which included body temperature: 97 something on 26Jan2021, 98.8 and 99 on 27Jan2021; sars-cov-2 test: positive on an unspecified date in 2020 and negative on an unspecified date in 2020. Outcome of the event "slight pain in his arm the shot was given" was recovering, while for the other events was unknown.
arm is still sore; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: arm is still sore). The outcome of the pain in arm was not recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK receipt date: 31-Mar-2023 The case was received from the patient via interactive digital media. The patient stated that his or she arm was still sore from the shot. The follow-up could not be possible as no contact details were available.